Ahmadreza Jamshidi

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 3

Top Topics

Juvenile Idiopathic Arthritis

Disease Activity

Top Venues

Journal of osteoporosis

Advances in therapy

Expert opinion on investigational drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Ahmadreza Jamshidi, Farhad Gharibdoost, Sima Sedighi, Asghar HajiAbbasi, Amir-Hossein Salari, Alireza Khabbazi, Peyman Mottaghi, Ahmad Tahammoli Roudsari, Mehrdad Aghaie, Irandokht Shenavar Masooleh, Araz Sabzvari, Nassim Anjidani
A Phase IV Study of the Safety and Efficacy of CinnoPar® in Iranian Patients with Osteoporosis. Journal of osteoporosis 2021 (2021)
Farhad Gharibdoost, Amir-Hossein Salari, Mansour Salesi, Faegheh Ebrahimi Chaharom, Peyman Mottaghi, Mansour Hosseini, Maryam Sahebari, Mohammadali Nazarinia, Zahra Mirfeizi, Mohammadreza Shakibi, Hamidreza Moussavi, Mansour Karimifar, Karim Mowla, Hadi Karimzadeh, Nassim Anjidani, Ahmadreza Jamshidi
Assessment of Treatment Safety and Quality of Life in Patients Receiving Etanercept Biosimilar for Autoimmune Arthritis (ASQA): A Multicenter Post-marketing Surveillance Study. Advances in therapy 38 (2) (2021)
Ahmadreza Jamshidi, Araz Sabzvari, Nassim Anjidani, Ramin Shahpari, Nima Badri
A randomized phase I pharmacokinetic trial comparing the potential biosimilar adalimumab (CinnoRA®) with the reference product (Humira®) in healthy volunteers. Expert opinion on investigational drugs 29 (3) (2020)